Related Experiment Video
Updated: May 23, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Cholesterol inhibits assembly and oncogenic activation of the EphA2 receptor
Ryan J Schuck1, Alyssa E Ward1, Amita R Sahoo2
1Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, TN, USA.
Abstract:
The receptor tyrosine kinase EphA2 drives cancer malignancy by facilitating metastasis. EphA2 can be found in different self-assembly states: as a monomer, dimer, and oligomer. However, we have a poor understanding regarding which EphA2 state is responsible for driving pro-metastatic signaling. To address this limitation, we have developed SiMPull-POP, a single-molecule method for accurate quantification of membrane protein self-assembly. Our experiments reveal that a reduction of plasma membrane cholesterol strongly promotes EphA2 self-assembly. Indeed, low cholesterol levels cause a similar effect to the EphA2 ligand ephrinA1-Fc. These results indicate that cholesterol inhibits EphA2 assembly. Phosphorylation studies in different cell lines reveal that low cholesterol increased phospho-serine levels in EphA2, the signature of oncogenic signaling. Investigation of the mechanism that cholesterol uses to inhibit the assembly and activity of EphA2 indicate an in-trans effect, where EphA2 is phosphorylated by protein kinase A downstream of beta-adrenergic receptor activity, which cholesterol also inhibits. Our study not only provides new mechanistic insights on EphA2 oncogenic function, but it also suggests that cholesterol acts as a molecular safeguard mechanism that prevents uncontrolled self-assembly and activation of EphA2.
Insights
Cholesterol inhibits the self-assembly and oncogenic signaling of the receptor tyrosine kinase EphA2, a key driver of cancer metastasis. Lowering cholesterol promotes EphA2 assembly, suggesting cholesterol acts as a safeguard against cancer progression.
Area of Science:
- Molecular biology
- Cell biology
- Cancer research
Background:
- Receptor tyrosine kinase EphA2 promotes cancer metastasis.
- EphA2 exists as monomers, dimers, and oligomers, but the pro-metastatic state is unknown.
- Understanding EphA2 self-assembly is crucial for targeting cancer malignancy.
Purpose of the Study:
- To investigate the role of EphA2 self-assembly states in pro-metastatic signaling.
- To develop a method for quantifying membrane protein self-assembly.
- To elucidate the regulatory role of cholesterol in EphA2 activity.
Main Methods:
- Development of SiMPull-POP, a single-molecule method for membrane protein self-assembly quantification.
- Cholesterol manipulation in plasma membranes.
- Phosphorylation studies in various cell lines.
- Investigation of signaling pathways involving protein kinase A and beta-adrenergic receptors.
Main Results:
- Reduced plasma membrane cholesterol significantly promotes EphA2 self-assembly, mimicking the effect of the EphA2 ligand.
- Cholesterol inhibits EphA2 assembly and phosphorylation at serine residues, a marker of oncogenic signaling.
- Cholesterol inhibits EphA2 activity via an in-trans mechanism involving protein kinase A and beta-adrenergic receptor signaling.
Conclusions:
- Cholesterol acts as an inhibitor of EphA2 self-assembly and oncogenic signaling.
- Low cholesterol levels enhance EphA2 assembly and promote pro-metastatic signaling.
- Cholesterol functions as a protective mechanism against uncontrolled EphA2 activation and cancer progression.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Amplifying Signals via Enzymatic Cascade

